paxilline has been researched along with Achondroplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baruzzi, A; Ferrarini, F; Liboi, E; Lievens, PM; Montone, R; Romanelli, MG | 1 |
1 other study(ies) available for paxilline and Achondroplasia
Article | Year |
---|---|
Mutant FGFR3 associated with SADDAN disease causes cytoskeleton disorganization through PLCĪ³1/Src-mediated paxillin hyperphosphorylation.
Topics: Achondroplasia; Amino Acid Substitution; Animals; Cell Line, Transformed; Cell Line, Tumor; Chondrocytes; Cytoskeleton; Humans; Mice; Mutation; Paxillin; Phospholipase C gamma; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Transport; Receptor, Fibroblast Growth Factor, Type 3; Recombinant Fusion Proteins; Signal Transduction; src-Family Kinases; Thanatophoric Dysplasia; Tyrosine | 2018 |